| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 228.56B | 226.57B | 230.78B | 244.32B | 260.41B | 201.55B |
| Gross Profit | 36.79B | 34.08B | 38.03B | 35.32B | 27.77B | 26.17B |
| EBITDA | 11.32B | 4.41B | 12.64B | 11.93B | 5.53B | 4.78B |
| Net Income | 6.29B | 4.75B | 7.00B | 6.79B | 986.00M | 1.95B |
Balance Sheet | ||||||
| Total Assets | 169.85B | 166.32B | 170.16B | 178.09B | 178.62B | 161.70B |
| Cash, Cash Equivalents and Short-Term Investments | 12.06B | 3.30B | 11.95B | 4.25B | 2.42B | 3.58B |
| Total Debt | 25.09B | 19.49B | 25.32B | 29.98B | 45.93B | 32.10B |
| Total Liabilities | 63.87B | 55.21B | 63.87B | 76.04B | 84.35B | 67.17B |
| Stockholders Equity | 105.50B | 110.57B | 105.81B | 101.61B | 93.85B | 94.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.87B | 13.82B | 18.82B | -13.99B | -20.75B |
| Operating Cash Flow | 0.00 | 3.00B | 18.29B | 22.47B | -10.02B | -16.81B |
| Investing Cash Flow | 0.00 | -3.52B | -3.78B | -3.34B | -3.71B | 1.92B |
| Financing Cash Flow | 0.00 | -8.21B | -6.86B | -17.35B | 12.63B | 10.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥41.47B | 15.74 | ― | 2.55% | 1.47% | 15.57% | |
71 Outperform | ¥575.76B | 28.74 | 9.28% | 1.30% | 5.86% | -17.47% | |
69 Neutral | ¥20.78B | 20.45 | ― | 2.54% | 5.51% | 386.06% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | ¥166.25B | 7.50 | 12.56% | 3.44% | 4.40% | 91.05% | |
58 Neutral | ¥65.59B | 14.05 | ― | 3.77% | -1.82% | -32.12% | |
51 Neutral | ¥305.85B | 27.71 | ― | 1.45% | 15.06% | 399.49% |